Published in J Psychiatr Res on October 23, 2002
Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects. J Neurolinguistics (2010) 1.01
Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depend (2009) 0.94
On identifying the processes underlying schizophrenic speech disorder. Schizophr Bull (2011) 0.90
Gaze strategies during planning in first-episode psychosis. J Abnorm Psychol (2007) 0.86
Dimensions of executive functioning in schizophrenia and their relationship with processing speed. Schizophr Bull (2010) 0.83
Impaired working speed and executive functions as frontal lobe dysfunctions in young first-degree relatives of schizophrenic patients. Eur Child Adolesc Psychiatry (2006) 0.79
Neurocognitive predictors of source monitoring in schizophrenia. Psychiatry Res (2012) 0.78
In your eyes only: deficits in executive functioning after frontal TMS reflect in eye movements. Front Behav Neurosci (2014) 0.77
A novel computational model to probe visual search deficits during motor performance. J Neurophysiol (2016) 0.75
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24
WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry (2010) 4.26
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry (2009) 1.71
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52
Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophr Res (2005) 1.48
Catatonia in DSM-5. Schizophr Res (2013) 1.43
Prediction of psychosis by mismatch negativity. Biol Psychiatry (2010) 1.38
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37
Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34
Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res (2014) 1.32
Definition and description of schizophrenia in the DSM-5. Schizophr Res (2013) 1.28
Attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.24
Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr Res (2013) 1.21
Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophr Res (2006) 1.21
Structure of the psychotic disorders classification in DSM-5. Schizophr Res (2013) 1.16
Side effects of atypical antipsychotics: a brief overview. World Psychiatry (2008) 1.13
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull (2010) 1.10
Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci (2008) 1.06
Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci (2009) 1.06
Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res (2007) 1.06
Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull (2007) 1.05
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04
Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res (2008) 1.03
German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci (2003) 1.01
Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv (2012) 1.00
Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry (2007) 1.00
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
Insufficient depression treatment in outpatient settings. Ger Med Sci (2004) 0.98
Self-reported utilization of mental health services in the adult German population--evidence for unmet needs? Results of the DEGS1-Mental Health Module (DEGS1-MH). Int J Methods Psychiatr Res (2014) 0.96
Schizoaffective Disorder in the DSM-5. Schizophr Res (2013) 0.95
Effects of abstinence on brain morphology in alcoholism: a MRI study. Eur Arch Psychiatry Clin Neurosci (2009) 0.94
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Int J Neuropsychopharmacol (2008) 0.93
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. Eur Arch Psychiatry Clin Neurosci (2014) 0.93
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol (2010) 0.93
The design and methods of the mental health module in the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res (2013) 0.92
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res (2009) 0.92
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial. Eur Arch Psychiatry Clin Neurosci (2014) 0.92
Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia. Schizophr Bull (2011) 0.91
Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology (Berl) (2006) 0.91
Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology (2011) 0.91
Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am J Hum Genet (2005) 0.90
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response? Eur Neuropsychopharmacol (2011) 0.89
Clinical predictors of response and remission in inpatients with depressive syndromes. J Affect Disord (2011) 0.89
αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology (2013) 0.89
Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2008) 0.88
Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines. Int J Qual Health Care (2005) 0.87
Prevention of rehospitalization in schizophrenia: results of an integrated care project in Germany. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Attitude towards adherence in patients with schizophrenia at discharge. J Psychiatr Res (2009) 0.87
Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care. Eur Psychiatry (2004) 0.86
Status of psychotic disorders in ICD-11. Schizophr Bull (2012) 0.86
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci (2011) 0.85
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. Int J Neuropsychopharmacol (2008) 0.85
Implementation of a schizophrenia practice guideline: clinical results. J Clin Psychiatry (2008) 0.85
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study. J Clin Psychopharmacol (2010) 0.85
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. J Clin Psychiatry (2010) 0.85
[Cost of care for depressive disorders in primary and specialized care in Germany]. Psychiatr Prax (2004) 0.85
Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study. Eur Arch Psychiatry Clin Neurosci (2011) 0.84
DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.84
Internal capsule size associated with outcome in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.84
Disturbed frontal gyrification within families affected with schizophrenia. J Psychiatr Res (2006) 0.84
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients. Eur Neuropsychopharmacol (2010) 0.84
Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity. J Affect Disord (2007) 0.83
Late-stage neurosyphilis presenting with severe neuropsychiatric deficits: diagnosis, therapy, and course of three patients. J Neurol (2011) 0.83
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Psychopathology (2012) 0.83
The hippocampus in families with schizophrenia in relation to obstetric complications. Schizophr Res (2008) 0.83
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response. Psychiatry Res (2008) 0.83
Needs-oriented discharge planning and monitoring for high utilisers of psychiatric services (NODPAM): design and methods. BMC Health Serv Res (2008) 0.83
Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. Behav Brain Res (2003) 0.83
Response trajectories in "real-world" naturalistically treated schizophrenia patients. Schizophr Res (2012) 0.82
An early improvement threshold to predict response and remission in first-episode schizophrenia. Br J Psychiatry (2010) 0.82
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenet Genomics (2009) 0.82
Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenet Genomics (2009) 0.82
Akathisia and suicidal ideation in first-episode schizophrenia. J Clin Psychopharmacol (2012) 0.82
Adherence to guidelines for treatment of depression in in-patients. Br J Psychiatry (2005) 0.82
The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats. Clinics (Sao Paulo) (2010) 0.82
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
The German Research Network on Schizophrenia--impact on the management of schizophrenia. Dialogues Clin Neurosci (2006) 0.81
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. J Psychiatr Res (2011) 0.81
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? World J Biol Psychiatry (2010) 0.81
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosci (2007) 0.80
Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes. J Clin Psychiatry (2004) 0.80
One-year functional outcomes of naturalistically treated patients with schizophrenia. Psychiatry Res (2012) 0.80
[Clinical practice guidelines for the diagnosis and therapy of depressive disorders in primary care]. Z Arztl Fortbild Qualitatssich (2003) 0.80
Prediction of symptom remission in schizophrenia during inpatient treatment. World J Biol Psychiatry (2009) 0.80
Facial expression in male and female schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2009) 0.80
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode. Eur Neuropsychopharmacol (2012) 0.79
The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial. Drug Alcohol Depend (2011) 0.79
Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. World J Biol Psychiatry (2011) 0.79
Validation of polypharmacy process measures in inpatient schizophrenia care. Schizophr Bull (2004) 0.78
[Reason for encounter and diagnosis of depression in patients in general practice]. Z Arztl Fortbild Qualitatssich (2003) 0.78
Behavioral and hippocampal changes after prenatal invasive interventions with possible relevance to schizophrenia. Behav Brain Res (2006) 0.78
Modular networks involving the medial frontal cortex: towards the development of neuropsychiatry. World J Biol Psychiatry (2010) 0.78
Psychopathology in the 21st century. World J Biol Psychiatry (2010) 0.78
[Comprehensive ambulatory care quality management for patients with depressive disorders]. Z Arztl Fortbild Qualitatssich (2003) 0.78